What research is being done on the SCN and cancer?
Ongoing research is focused on unraveling the complex interactions between the SCN and cancer. Scientists are exploring how circadian rhythms influence tumor microenvironments, immune responses, and metabolism. Additionally, there is growing interest in developing pharmacological agents that target circadian pathways to enhance cancer treatment. Animal studies and clinical trials are underway to better understand how manipulating the circadian clock can prevent cancer and improve therapeutic outcomes.
